Belgium-based brain-imaging AI company icometrix has announced that it has received a CPT III code from the American Medical Association, allowing it to reimburse medical expenses. FDA-cleared brain MRI quantification software.
icometrix AI-supported quantitative brain analysis software helps clinicians diagnose, monitor and assess treatment response in patients with neurological disorders such as Alzheimer’s disease, dementia, multiple sclerosis, epilepsy, stroke and Parkinson’s disease. Provides useful brain MRI scan indicators.
The CPT Code will allow qualified medical professionals to report the use of icometrix Brain Imaging AI software as medical expenses.
the bigger trend
The company received Raised $18 million in 2019 to grow brain software. A Belgian company received FDA clearance for its icobrain-ctp product in February 2020.
Last month, the company announced that it has won a grant from the Michael J. Fox Foundation to study brain MRI biomarkers for Parkinson’s disease in collaboration with Professor of Neurology and Neuroscience at Stanford University School of Medicine.
In March the company received £1,417,658 ($1,798,944) Receives a grant from the National Institutes of Health Research to accelerate imaging research in multiple sclerosis.
Another company using AI software to help medical workers diagnose brain disorders is a South Korean health tech company Neurofet. In April, AI-based degenerative brain disease diagnosis support software was certified by the Singapore Health Sciences Agency.
